Top Markets
Coin of the day
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Classement en actions #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Prix de l'action
$0.07
Dernière synchronisation: 2024-11-12
Capitalisation boursière
$1.62M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange Peak Bio, Inc. (PKBO)

Catégorie

Historique des divisions d’actions pour Peak Bio, Inc. (PKBO)
L’action Peak Bio, Inc. (symbole : PKBO) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 15, 2026.
Une action PKBO achetée avant le Aug 15, 2026 équivaudrait aujourd’hui à 0 actions PKBO.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
0 -
CH
0 -
KR
0 -
BE